We’re back with the fumble. Last week I was indisposed, apologies. A sexy nurse was slicing open my right arm and stuffing a camera through the artery all the way to my heart.
I have one! My ex-wife would disagree.
It’s a procedure called a coronary angiogram. If you’ve got a spare two thousand dollars lying around and nothing to do on a Friday afternoon I highly recommend it.
When you’re laying on the table you won’t be thinking about your portfolio. I guarantee you!
If you’re anything like me, you’ve got more pressing concerns like the fact they were running Windows XP to control a lot of their gear.
What? That shit could crash any minute and take me with it.
Anyway – All’s well that end’s well. Like my old man used to say to me: “If I’d known I was going to live this long I would have treated myself better.”
Speaking of near heart attacks, did you catch the madness which played out on Tilray (TLRY.NASDAQ) last week?
A few market themes to keep an eye on
Everything Equity Guru’s Chris Parry writes is top shelf. Occasionally though, a piece comes out which warrants closer attention.
A “must read” as they say.
e-what? Yeah, I hear you. I played some Sega Mega Drive back in the day, lounging around with my then girlfriend taking bong hits while listening to Cypress Hill. They were happy, if somewhat unproductive, days.
Gaming never got under my skin. At least, not in a big way.
But here’s the thing – there’s a ton of people out there who love it and even a bunch of folks making insane amounts of money off it.
As an investor, it’s something you need to try and get your head around now. The investment opportunities will appear before long.
Chance favors the prepared mind.
2. Gold ain’t dead
We gave you the heads-up that Royal Nickel Corp (RNX.T) was going on a run after they hit the ‘mother lode’ at Beta Hunt in WA.
When the shares resumed trading on Monday September 10, 2018, they promptly doubled from 9c to 18c. Since then they have 4-bagged and closed September 26th at $0.83.
Well done to anyone who scooped up a few dollars trading this one.
Here’s the takeaway – Even if the POG (Price of Gold) ain’t marching forward, under the right circumstances investors are still pumping money into gold juniors.
This has been a great, straight-forward trade for anyone who had their eyes and ears open.
ASX Happenings – Time to rattle the tin
Two cannabis companies have halted trading on their securities pending capital raisings:
1. Elixinol Global (EXL.ASX)
It was always going to be a matter of when, not if, EXL punched into blue sky.
We mentioned this on the fumble a fortnight back when we told you hemp was hot
When it likely punches into blue-sky in the coming days there won’t be much selling pressure meaning buyers will have to pay up to get orders filled.
That old $1.99 high is dust. On Wednesday 26th the stock punched out to a new all-time high of $2.15. It had been flirting with the two buck level for the past week or so.
Today when we checked Google Finance there was no market data for EXL. Knew straight away what had happened without needing to check the ASX announcements.
Is EXL using that old play of raising capital on the back of a strong share price?
Yep, sure enough, that’s why the shares have been halted, most likely until the coming Monday.
We’re guessing the offering will be priced somewhere in the $1.85 – $1.90 range. Let’s see how close we are 😉
Turns out it’s $1.85 according to the AFR – the office crystal ball is still working well. A $40 mill raise too – that’s a big one!
This is a smart opportunistic play from the company, but as we show below, shareholders should expect some short-term pain.
2. BOD Australia (BDA.ASX)
The AFR Street Talk column has the goss on this one.
A $5.8 million raise at 53c a share, lead by Canaccord Genuity and Taylor Collison.
With the shares closing at 60c on September 25th the offering seems fairly priced.
Makes sense but cap raisings haven’t been a great deal for existing shareholders.
Let’s look at how this has played out with other pot plays:
- Creso Pharma (CPH.ASX) raised capital at $1.10 in November, 2017 – shares now trading at $0.56
- AusCann (AC8.ASX) raised capital at $1.10 in July, 2018 – shares now trading at $1.00
- Medlab Clinical (MDC.ASX) raised capital at $0.89 in Juanuary, 2018 – shares now trading at $0.46
Top 5 Financial Reads
Are trading books still a thing? When I was working in the Sydney CBD I’d spend many an hour at Dymocks flagship store on George St, packing into the scrum of blokes (never saw many sheila’s) who were huddled around the finance section.
Anyway, as someone who spent most of his weekly wage on books at one stage, here are my top five.
Don’t agree? Then jump into the comments section and say so!
- The Zurich Axioms – Max Gunther
Filled with what I believe are trading gems which have stood the test of time.
“Adventure is what makes life worth living, and the way to have an adventure is to expose yourself to risk.”
― Max Gunther, The Zurich Axioms
The Black Swan – Nassim Nicholas Taleb
“The three most harmful addictions are heroin, carbohydrates, and a monthly salary.”
― Nassim Nicholas Taleb
Everything by Taleb is good. Read’em all. One of my favourites right here.
Market Wizards – Jack D. Schwager
For many of my generation this is the book which started it all. Should be on the bookshelf of every serious trader.
“A losing trader can do little to transform himself into a winning trader. A losing trader is not going to want to transform himself. That’s the kind of thing winning traders do.” – Ed Seykota
The Inner game of Tennis – W. Timothy Gallwey
Have I lost my mind?
You need to tackle the physcological aspect of losing money. Sure Steenbargers stuff is good and so is Douglas (Trading in the Zone) but this is a hidden gem.
“Fighting the mind does not work. What works best is learning to focus it.”
Pitbull – Marty Schwartz
I no longer have my copy (the advantages of a Kindle – when you own a tonne of books and move 3000km not all of them will make the journey with you!) but read it many times.
“I always laugh at people who say “I’ve never met a rich technician.” I love that! It’s such an arrogant, nonsensical response. I used fundamentals for 9 years and got rich as a technician – Marty Schwartz
One of my favourite Wizards.
I’d better go – with the coffers running extremely low this week it’s time to play one of my favorite games. I walk around the condo and constantly ask myself: “If I was a 100-baht note, where would I be hiding?”
–// Craig Amos
(Feature image courtesy of giphy.com)
Book covers: Amazon.com
Castle Wolfenstein: Ebay.com
FULL DISCLOSURE: None of the companies mentioned here are Equity Guru clients.Disclaimer: ALWAYS DO YOUR OWN RESEARCH and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment.
Latest posts by Craig Amos (see all)
- Creso Pharma (CPH.ASX) puts retail bagholders to the sword with PharmaCielo (PCLO.V) deal - June 10, 2019
- Adventures of a crypto newbie: Netflix, no Lamborghini - April 11, 2019
- AUDIO: Equity Guru talks to ABC Radio’s NT Country Hour about Wayland Group’s (WAYL.C) Tropicann acquisition - December 19, 2018